Eleotin Philosophy
Natural health product licensed in Canada
- Licence holder
- Eastwood Bio-Medical Research Inc.
- NPN or DIN-HM
- 80087697
- Status
- Active licence
- Licence date
- 8 August 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 milligramme Potency : 6 milligramme Terpene lactones | 100 milligramme | Not calculated |
| Cannabis sativa Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1,600 milligramme | 400 milligramme | Not calculated |
| Rhodiola rosea Source : Racine et rhizome Potency : 1 milligramme Salidroside | 100 milligramme | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,000 milligramme | 200 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24 milligramme Flavonoid glycosides | Not specified | Not calculated |
| Rhodiola rosea Source : Racine et rhizome Potency : 3.5 milligramme Rosavins | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Huo ma ren, Ginkgo Biloba, Rhodiola, and Korean Red Ginseng are a combination of Traditinal Chinese Medicine ingredients. Provides antioxidants. Helps to enhance cognitive function and memory in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have diabetes, high blood pressure, or seizures, or if you are taking antidepressants,blood thinners, digoxin, hormone replacement therapy (HRT), birth control pills, or medications for diabetes. According to TCM, do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency.
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
- Contre-indications
Do not use if you have bipolar disorder or bipolar spectrum disorder, or if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80087697
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.